[go: up one dir, main page]

MX2014012822A - Proceso para elaborar derivados de naftiridina. - Google Patents

Proceso para elaborar derivados de naftiridina.

Info

Publication number
MX2014012822A
MX2014012822A MX2014012822A MX2014012822A MX2014012822A MX 2014012822 A MX2014012822 A MX 2014012822A MX 2014012822 A MX2014012822 A MX 2014012822A MX 2014012822 A MX2014012822 A MX 2014012822A MX 2014012822 A MX2014012822 A MX 2014012822A
Authority
MX
Mexico
Prior art keywords
manufacturing
naphthyridine derivatives
compounds
naphthyridine
derivatives
Prior art date
Application number
MX2014012822A
Other languages
English (en)
Inventor
Stefan Abele
Gunther Schmidt
Hans Meier
Heinz Steiner
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of MX2014012822A publication Critical patent/MX2014012822A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Electric Double-Layer Capacitors Or The Like (AREA)
  • Treating Waste Gases (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Secondary Cells (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

La invención se relaciona con un proceso novedoso adecuado para elaborar el compuesto de la fórmula (I) (ver Fórmula) donde W es H, Br, CI o metilo, que son intermediarios sintéticos útiles en la preparación de compuestos antibióticos.
MX2014012822A 2012-04-27 2013-04-26 Proceso para elaborar derivados de naftiridina. MX2014012822A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12002989 2012-04-27
PCT/IB2013/053306 WO2013160875A1 (en) 2012-04-27 2013-04-26 Process for manufacturing naphthyridine derivatives

Publications (1)

Publication Number Publication Date
MX2014012822A true MX2014012822A (es) 2015-02-10

Family

ID=48670012

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014012822A MX2014012822A (es) 2012-04-27 2013-04-26 Proceso para elaborar derivados de naftiridina.

Country Status (14)

Country Link
US (1) US9187476B2 (es)
EP (1) EP2841434B1 (es)
JP (1) JP2015518487A (es)
KR (1) KR20150006006A (es)
CN (1) CN104220439B (es)
AR (1) AR090844A1 (es)
CA (1) CA2869288A1 (es)
DK (1) DK2841434T3 (es)
ES (1) ES2569393T3 (es)
HU (1) HUE028979T2 (es)
IL (1) IL235300A0 (es)
MX (1) MX2014012822A (es)
TW (1) TW201345905A (es)
WO (1) WO2013160875A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR089929A1 (es) 2012-02-10 2014-10-01 Actelion Pharmaceuticals Ltd Proceso para manufacturar un derivado de naftiridina
JP6112724B2 (ja) * 2013-10-31 2017-04-12 日本化薬株式会社 １，５−ナフチリジン誘導体およびそれを有効成分として含んでなる殺虫剤

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325757D0 (en) * 1993-12-16 1994-02-16 Zeneca Ltd Fluorination process
US6203671B1 (en) * 1999-03-10 2001-03-20 Alliedsignal Inc. Method of producing fluorinated compounds
NZ523749A (en) 2000-07-26 2005-03-24 Smithkline Beecham P Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
TW200427688A (en) * 2002-12-18 2004-12-16 Glaxo Group Ltd Antibacterial agents
JP2008509222A (ja) * 2004-08-09 2008-03-27 グラクソ グループ リミテッド 抗菌剤
DE102004041163A1 (de) * 2004-08-25 2006-03-02 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
US7648980B2 (en) 2005-01-25 2010-01-19 Glaxo Group Limited Antibacterial agents
US7511035B2 (en) 2005-01-25 2009-03-31 Glaxo Group Limited Antibacterial agents
US7709472B2 (en) 2005-01-25 2010-05-04 Glaxo Group Limited Antibacterial agents
JP2008528598A (ja) 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
US7592334B2 (en) 2005-01-25 2009-09-22 Glaxo Group Limited Antibacterial agents
CA2608072A1 (en) * 2005-05-24 2006-11-30 Astrazeneca Ab Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
WO2007016610A2 (en) * 2005-08-02 2007-02-08 Glaxo Group Limited Antibacterial agents
EP2029612A1 (en) * 2006-06-09 2009-03-04 Glaxo Group Limited Substituted 1-methyl-1h-quinolin-2-ones and 1-methyl-1h-1,5-naphthyridin-2-ones as antibacterials
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
GB0707708D0 (en) * 2007-04-20 2007-05-30 Glaxo Group Ltd Compounds
EP2080761A1 (en) * 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
AU2009325902B2 (en) 2008-12-12 2015-01-29 Idorsia Pharmaceuticals Ltd 5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives
EP2379554B1 (en) * 2009-01-15 2015-11-11 Glaxo Group Limited Naphthyridin-2(1h)-one compounds useful as antibacterials
CA2750047A1 (en) * 2009-01-21 2010-07-29 Basilea Pharmaceutica Ag Novel bicyclic antibiotics
KR20130108975A (ko) * 2010-04-30 2013-10-07 인디애나 유니버시티 리서치 앤드 테크놀로지 코포레이션 리네졸리드의 제조 방법
GB201118675D0 (en) * 2011-10-28 2011-12-14 Astex Therapeutics Ltd New compounds
AR089929A1 (es) 2012-02-10 2014-10-01 Actelion Pharmaceuticals Ltd Proceso para manufacturar un derivado de naftiridina

Also Published As

Publication number Publication date
ES2569393T3 (es) 2016-05-10
DK2841434T3 (en) 2016-05-30
US9187476B2 (en) 2015-11-17
EP2841434B1 (en) 2016-03-02
EP2841434A1 (en) 2015-03-04
JP2015518487A (ja) 2015-07-02
WO2013160875A1 (en) 2013-10-31
AR090844A1 (es) 2014-12-10
TW201345905A (zh) 2013-11-16
CA2869288A1 (en) 2013-10-31
US20150087840A1 (en) 2015-03-26
CN104220439A (zh) 2014-12-17
IL235300A0 (en) 2014-12-31
HUE028979T2 (en) 2017-02-28
CN104220439B (zh) 2016-08-24
KR20150006006A (ko) 2015-01-15

Similar Documents

Publication Publication Date Title
IN2014MN02496A (es)
CO6852084A2 (es) Nuevos compuestos sustituidos con halógeno
AU2012334173A8 (en) [1, 2, 3] triazolo [4, 5 -d] pyrimidine derivatives as agonists of the cannabinoid receptor 2
NZ726356A (en) Processes for preparing antiviral compounds
AU2012213775A8 (en) 7-azaindole derivatives
IN2014MN01521A (es)
NZ711192A (en) Process for making benzoxazepin compounds
IN2014DN00144A (es)
AU2012342891A8 (en) 3-Cyanoaryl-1H-pyrrolo[2.3-b]pyridine derivatives
MY169028A (en) Process for making hydroxylated cyclopentylpyrimidine compounds
WO2011157390A3 (en) Process for the preparation of substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds
TN2013000354A1 (en) Synthesis of 2-carboxamide cycloamino urea derivatives
UA113086C2 (xx) Піразольні сполуки як інгібітори sglt1
IN2014KN01062A (es)
WO2012140490A3 (en) Processes for preparing pitavastatin calcium
WO2014087208A3 (en) A process of preparing alcaftadine
IN2014DN09451A (es)
WO2013190357A8 (en) A process for the preparation of gabapentin
MY174153A (en) Processes for the preparation of pyrimidinylcyclopentane compounds
CA2862757A1 (en) Process for manufacturing a naphthyridine derivative
MX2014012822A (es) Proceso para elaborar derivados de naftiridina.
TN2017000065A1 (en) A tetrahydropyrrolo[3,4-d][1,3]thiazine-derivative as bace inhibitor
WO2015004687A3 (en) Novel tricyclic compounds and process for preparation thereof
MX2013002656A (es) Nuevo proceso.
IN2013MU03670A (es)